Literature DB >> 1544229

Abnormal urothelial HLA-DR expression in interstitial cystitis.

T J Christmas1, G F Bottazzo.   

Abstract

Interstitial cystitis is a chronic inflammatory disorder of the urinary bladder that predominantly afflicts middle-age women. The end stage of the disease is ulceration of the urothelium, the so-called Hunner's ulcer. The aetiology of interstitial cystitis remains obscure. We have studied bladder biopsies from 22 cases of interstitial cystitis and control groups consisting of six cases of bacterial cystitis and eight healthy women. Indirect immunofluorescence was performed on the biopsies using murine MoAbs to human HLA class I molecules, and class II molecules, HLA-DP, HLA-DQ and HLA-DR. In interstitial cystitis, bacterial cystitis and normal controls most cells expressed HLA class I products. In six cases of interstitial cystitis and one case of bacterial cystitis there was evidence of HLA class I hyperexpression. In normal bladder and bacterial cystitis HLA class II expression was restricted to submucosal dendritic cells, Langerhans cells macrophages, vascular endothelial cells and activated lymphocytes. All but two cases of interstitial cystitis showed surface expression of HLA-DR (but not HLA-DP or DQ). In all cases of interstitial cystitis there was an increase in the numbers of macrophages, activated lymphocytes and vascular endothelial cells expressing HLA class II molecules within the submucosa. These findings provide further evidence for the importance of inappropriate HLA molecule expression in a disease suspected of having an autoimmune pathogenesis and where cellular autoimmune mechanisms play a decisive role in the destruction of the target cells--the bladder urothelium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544229      PMCID: PMC1554339          DOI: 10.1111/j.1365-2249.1992.tb03018.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Absence of retroviral sequences in Graves' disease.

Authors:  M Humphrey; J Mosca; J R Baker; J J Drabick; F E Carr; D S Burke; L Wartofsky; Y Y Djuh; K D Burman
Journal:  Lancet       Date:  1991-01-05       Impact factor: 79.321

2.  Immunohistochemical analysis of the human bladder.

Authors:  R A Gardiner; G J Seymour; M F Lavin; G M Strutton; E Gemmell; G Hazan
Journal:  Br J Urol       Date:  1986-02

3.  [Rheumatoid polyarthritis and interstitial cystopathy].

Authors:  G Chantepie; O Leloire; C Creusy; G Duquesne; G Vincent
Journal:  Ann Urol (Paris)       Date:  1986

4.  Immunologic aspects of interstitial cystitis.

Authors:  H L Gordon; R D Rossen; E M Hersh; J J Yium
Journal:  J Urol       Date:  1973-02       Impact factor: 7.450

5.  Bladder antibodies in interstitial cystitis.

Authors:  M R Silk
Journal:  J Urol       Date:  1970-03       Impact factor: 7.450

6.  Immune complex-mediated interstitial cystitis as a major manifestation of systemic lupus erythematosus.

Authors:  E Boye; M Morse; I Huttner; B F Erlanger; K J MacKinnon; J Klassen
Journal:  Clin Immunol Immunopathol       Date:  1979-05

Review 7.  Interstitial cystitis as an autoimmune disease. A review.

Authors:  K J Oravisto
Journal:  Eur Urol       Date:  1980       Impact factor: 20.096

8.  Retrovirus-like sequences in Graves' disease: implications for human autoimmunity.

Authors:  A Ciampolillo; V Marini; R Mirakian; M Buscema; T Schulz; R Pujol-Borrell; G F Bottazzo
Journal:  Lancet       Date:  1989-05-20       Impact factor: 79.321

9.  Lupus cystitis: primary bladder manifestations of systemic lupus erythematosus.

Authors:  R W Orth; M H Weisman; A H Cohen; L B Talner; D Nachtsheim; N J Zvaifler
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

10.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

View more
  7 in total

Review 1.  Interstitial cystitis.

Authors:  D R Erickson; M F Davies
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

2.  RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model.

Authors:  Wujiang Liu; Barry R Deyoung; Xiaohong Chen; David P Evanoff; Yi Luo
Journal:  J Autoimmun       Date:  2007-12-26       Impact factor: 7.094

3.  Estrogen receptor beta-deficient female mice develop a bladder phenotype resembling human interstitial cystitis.

Authors:  Otabek Imamov; Konstantin Yakimchuk; Andrea Morani; Thomas Schwend; Osamu Wada-Hiraike; Sergei Razumov; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-23       Impact factor: 11.205

4.  Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli.

Authors:  Joel D Schilling; Steven M Martin; Chia S Hung; Robin G Lorenz; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

5.  Urothelial antigen-specific CD4+ T cells function as direct effector cells and induce bladder autoimmune inflammation independent of CD8+ T cells.

Authors:  W Liu; X Chen; D P Evanoff; Y Luo
Journal:  Mucosal Immunol       Date:  2011-01-26       Impact factor: 7.313

Review 6.  Evidence for bladder urothelial pathophysiology in functional bladder disorders.

Authors:  Susan K Keay; Lori A Birder; Toby C Chai
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411

7.  Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice.

Authors:  Kenan Izgi; Cengiz Z Altuntas; Fuat Bicer; Ahmet Ozer; Cagri Sakalar; Xiaoxia Li; Vincent K Tuohy; Firouz Daneshgari
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.